These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25432410)

  • 1. (R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment.
    Madan RA; Gulley JL
    J Natl Cancer Inst; 2015 Jan; 107(1):347. PubMed ID: 25432410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging of Immunotherapy Targets in Cancer.
    Ehlerding EB; England CG; McNeel DG; Cai W
    J Nucl Med; 2016 Oct; 57(10):1487-1492. PubMed ID: 27469363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonotyping for precision oncology.
    Dang HX; Maher CA
    Drug Discov Today; 2015 Dec; 20(12):1464-9. PubMed ID: 26494143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotargeting and personalized therapies in genitourinary cancers.
    Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Ciccarese C; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Future Oncol; 2016 Aug; 12(16):1853-6. PubMed ID: 27113700
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.
    Lazaro T; Brastianos PK
    CNS Oncol; 2017 Apr; 6(2):139-151. PubMed ID: 28425754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targeted therapies in pancreatic cancer.
    Seicean A; Petrusel L; Seicean R
    World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-based immunotherapy of solid cancers: progress and possibilities.
    Nicodemus CF
    Immunotherapy; 2015; 7(8):923-39. PubMed ID: 26314410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
    Kersh AE; Ng S; Chang YM; Sasaki M; Thomas SN; Kissick HT; Lesinski GB; Kudchadkar RR; Waller EK; Pollack BP
    J Clin Pharmacol; 2018 Jan; 58(1):7-24. PubMed ID: 29136276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives.
    Atkins MB; Larkin J
    J Natl Cancer Inst; 2016 Jun; 108(6):djv414. PubMed ID: 26839346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery.
    Gilboa E; Berezhnoy A; Schrand B
    Cancer Immunol Res; 2015 Nov; 3(11):1195-200. PubMed ID: 26541880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapping the treasure of intracellular oncotargets with immunotherapy.
    Hong CW; Zeng Q
    FEBS Lett; 2014 Jan; 588(2):350-5. PubMed ID: 24184114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next Generation of Lung Cancer Management.
    Levy B
    Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition.
    Lau PK; Ascierto PA; McArthur G
    Curr Opin Immunol; 2016 Apr; 39():30-8. PubMed ID: 26765776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches.
    Pandya PH; Murray ME; Pollok KE; Renbarger JL
    J Immunol Res; 2016; 2016():4273943. PubMed ID: 28116316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy and targeted therapy for cervical cancer: an update.
    Menderes G; Black J; Schwab CL; Santin AD
    Expert Rev Anticancer Ther; 2016; 16(1):83-98. PubMed ID: 26568261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.